Lihong Yun

Title: Lihong Yun: Innovator in Fusion Protein Technology

Introduction

Lihong Yun is a prominent inventor based in Jiangsu, China. He has made significant contributions to the field of biotechnology, particularly in the development of fusion proteins. His innovative work has led to advancements that could have a lasting impact on medical treatments.

Latest Patents

Lihong Yun holds a patent for a trophic hormone fusion protein, which includes a preparation method and its applications. The patent describes a gonadotropin fusion protein or a thyroid stimulating hormone fusion protein. This invention involves fusing the β-subunit of the gonadotropin or thyroid stimulating hormone to an Fc fragment, either directly or through a linker. The α-subunit binds to the β-subunit through an affinity interaction. This fusion protein is notable for its prolonged half-life and reduced activity fluctuations, making it a valuable asset in therapeutic applications.

Career Highlights

Lihong Yun is associated with Suzhou Alphamab Co., Ltd., where he continues to work on innovative solutions in biotechnology. His expertise in fusion protein technology has positioned him as a key player in the industry.

Collaborations

Lihong collaborates with notable colleagues, including Ting Xu and Kangping Guo, who contribute to his research and development efforts.

Conclusion

Lihong Yun's work in fusion protein technology exemplifies the innovative spirit of modern biotechnology. His contributions are paving the way for new therapeutic options and enhancing our understanding of hormone functions.